DE69006385T2 - Pharmazeutische Formulierung. - Google Patents

Pharmazeutische Formulierung.

Info

Publication number
DE69006385T2
DE69006385T2 DE69006385T DE69006385T DE69006385T2 DE 69006385 T2 DE69006385 T2 DE 69006385T2 DE 69006385 T DE69006385 T DE 69006385T DE 69006385 T DE69006385 T DE 69006385T DE 69006385 T2 DE69006385 T2 DE 69006385T2
Authority
DE
Germany
Prior art keywords
medicament
pharmaceutical formulation
chewable
tablet
chewability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69006385T
Other languages
English (en)
Other versions
DE69006385D1 (de
Inventor
Ian James Bolt
David Roy Merrifield
Paul Laurence Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE69006385D1 publication Critical patent/DE69006385D1/de
Publication of DE69006385T2 publication Critical patent/DE69006385T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
DE69006385T 1989-04-28 1990-04-26 Pharmazeutische Formulierung. Expired - Fee Related DE69006385T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909793A GB8909793D0 (en) 1989-04-28 1989-04-28 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
DE69006385D1 DE69006385D1 (de) 1994-03-17
DE69006385T2 true DE69006385T2 (de) 1994-05-19

Family

ID=10655920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69006385T Expired - Fee Related DE69006385T2 (de) 1989-04-28 1990-04-26 Pharmazeutische Formulierung.

Country Status (17)

Country Link
US (2) US5225197A (de)
EP (1) EP0396335B1 (de)
JP (1) JP2992761B2 (de)
KR (1) KR0167554B1 (de)
AT (1) ATE101034T1 (de)
AU (1) AU627298B2 (de)
CA (1) CA2015536C (de)
CY (1) CY1957A (de)
DE (1) DE69006385T2 (de)
DK (1) DK0396335T3 (de)
ES (1) ES2062353T3 (de)
GB (1) GB8909793D0 (de)
HK (1) HK1004522A1 (de)
IE (1) IE63806B1 (de)
NZ (1) NZ233441A (de)
PT (1) PT93877B (de)
ZA (1) ZA903181B (de)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
DK0494972T3 (da) * 1989-10-02 1997-05-12 Cima Labs Inc Brusedosisform samt fremgangsmåde til administration heraf
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
GB9009473D0 (en) 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
GB9027827D0 (en) * 1990-12-21 1991-02-13 Glaxo Laboratoires Pharmaceutical compositions
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
JPH06505498A (ja) * 1991-04-04 1994-06-23 ザ、プロクター、エンド、ギャンブル、カンパニー 咀嚼性制酸組成物
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
EP0574624B1 (de) * 1992-06-17 1997-09-10 Laboratoires Glaxo Sa Arzneimittel
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
NZ250363A (en) * 1992-12-04 1996-11-26 Susanna Elizabeth Chalmers A topical dressing containing a dessicant and an antimicrobial or antiseptic agent
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2709420B1 (fr) * 1993-09-01 1995-11-17 Sogeval Comprimé vétérinaire plus spécialement destiné aux chats.
FI103442B (fi) * 1993-09-24 1999-06-30 Nokia Telecommunications Oy Digitaalinen radiolinkkijärjestelmä ja radiolinkkilaite
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
WO1996037182A1 (en) * 1995-05-26 1996-11-28 Tom Kalili Chewing gum with fluoride and citric acid
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
FR2732217B1 (fr) * 1995-03-29 1997-06-06 Hesnard Xavier Forme d'administration solide a usage oral
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IN182040B (de) * 1995-06-13 1998-12-12 American Home Prod
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
BR9610396A (pt) * 1995-09-07 1999-07-06 Smithkline Beecham Corp Formulação farmacêutica
IL115357A (en) * 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
US6083531A (en) * 1996-04-16 2000-07-04 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US6667056B2 (en) 1997-07-23 2003-12-23 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US6673380B2 (en) 1998-11-17 2004-01-06 Mcneil-Ppc, Inc. Fortified confectionery delivery systems and methods of preparation thereof
AU2640599A (en) * 1998-02-26 1999-09-15 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
CN1237958C (zh) 1998-06-11 2006-01-25 法玛西雅厄普约翰美国公司 一种非缓释的、非咀嚼的药物片剂组合物
US6365182B1 (en) 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US20020006433A1 (en) * 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
DK1309315T3 (da) * 2000-08-18 2006-10-09 Pharmacia Corp Hurtigt disintegrerende oral valdecoxib-formulering
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1345592A2 (de) * 2000-12-06 2003-09-24 Pharmacia Corporation Sich schnell auflösende pharmazeutische zubereitung enthaltend schäumungsmittel
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
CN102600104B (zh) 2002-04-25 2015-06-24 旗帜药物胶囊公司 可咀嚼的软胶囊
US7189416B2 (en) * 2002-11-23 2007-03-13 Glykon Technologies Group, Llc Method for stable and controlled delivery of (-)-hydroxycitric acid
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
WO2005051350A2 (en) * 2003-10-28 2005-06-09 Torrent Pharmaceuticals Limited Water dispersible tablet
US20070048375A1 (en) * 2003-12-19 2007-03-01 Wolfgang Wiehl Effervescent preparation of a basic medicinally active substance
EP1708685B1 (de) 2003-12-31 2011-03-09 Cima Labs Inc. Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
BRPI0418228B8 (pt) 2003-12-31 2021-05-25 Cima Labs Inc forma de dosagem, e, método de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
CN1968682A (zh) * 2004-06-18 2007-05-23 株式会社柳韩洋行 包含表面改性的碳酸氢钠的阿莫西林和/或克拉维酸口服分散片组合物
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
US20090004270A1 (en) * 2006-01-06 2009-01-01 Amerilab Technologies, Inc. Method of using guava extract
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
HUE028847T2 (en) 2010-02-17 2017-01-30 Veloxis Pharmaceuticals As Stabilized tacrolimus preparation
EP2649989B1 (de) 2012-04-13 2017-10-18 King Saud University Verfahren zur Herstellung einer Feststoffdispersion, damit hergestellte Feststoffdispersion und Verwendung dafür
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
ES2541723T3 (es) 2012-06-12 2015-07-24 The Procter & Gamble Company Forma de dosificación efervescente
JP6253393B2 (ja) * 2013-12-19 2017-12-27 花王株式会社 固形状組成物
EP3860599A1 (de) 2018-10-04 2021-08-11 Adeptio Pharmaceuticals Limited (+)-alpha-dihydrotetrabenazin-dosierungsschema zur behandlung von bewegungsstörungen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1098116A (fr) * 1954-01-07 1955-07-18 Marocaine De Prod Chim Et Agri Procédé de fabrication de glossettes contenant des compositions destinées à l'absorption intratissulaire
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
FR2294M (fr) * 1962-07-30 1964-01-27 Dausse Lab Composition a base de sorbitol.
GB1113492A (en) * 1964-05-20 1968-05-15 Bristol Myers Co Chewable tablets comprising a penicillin antibiotic
SE369036B (de) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
US4127645A (en) * 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
EP0272265B1 (de) * 1985-09-25 1991-05-22 Gergely, Gerhard, Dr. Zerfallstablette und verfahren zu ihrer herstellung
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles

Also Published As

Publication number Publication date
JP2992761B2 (ja) 1999-12-20
CA2015536C (en) 1999-08-24
IE63806B1 (en) 1995-06-14
DK0396335T3 (da) 1994-03-07
NZ233441A (en) 1992-03-26
KR0167554B1 (ko) 1999-01-15
EP0396335B1 (de) 1994-02-02
CY1957A (en) 1990-04-26
PT93877B (pt) 1996-09-30
CA2015536A1 (en) 1990-10-28
KR900015716A (ko) 1990-11-10
AU627298B2 (en) 1992-08-20
ATE101034T1 (de) 1994-02-15
AU5391490A (en) 1990-11-01
EP0396335A1 (de) 1990-11-07
IE901489L (en) 1990-10-28
PT93877A (pt) 1990-11-20
HK1004522A1 (en) 1998-11-27
DE69006385D1 (de) 1994-03-17
JPH02295919A (ja) 1990-12-06
US5225197A (en) 1993-07-06
GB8909793D0 (en) 1989-06-14
US5962022A (en) 1999-10-05
ZA903181B (en) 1991-06-26
ES2062353T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DE69006385D1 (de) Pharmazeutische Formulierung.
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
CA2061917A1 (en) Pediatric effervescent dosage form
ATE297191T1 (de) Im munde schnellzerfallende tablette
DE3681582D1 (de) Pharmazeutische zubereitung mit abgabeeigenschaften.
IT1208735B (it) Formulazioni farmaceutiche a basedi arecolina e simili,lore preparazione ed impiego nel trattamento di disturbi della memoria
DK1741426T3 (da) Smelteekstruderede oralt administrerbare hydromorphonformuleringer
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
DK0404490T3 (da) Hurtigt opløselige doseringsformer
SE8803486L (sv) Dosform foer behandling av kardiovaskulaera sjukdomar
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
ATE73329T1 (de) Pharmazeutische zusammensetzungen.
DE3774415D1 (de) Pharmazeutische zusammensetzung fuer die prophylaxe und die therapie des magengeschwuers.
DE69120536T2 (de) Arzneimittel
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
ATE15139T1 (de) Phosphonomycine pharmazeutische zusammensetzung in tablettenform.
DE510561T1 (de) Pharmazeutische zusammensetzungen fuer die orale, kutane und intravaginale anwendung in form eines schaums.
FR2790201B1 (fr) Preparations therapeutiques a base d'alcool ethylique et de vitamines
邝安堃 et al. EFFECT OF OIGONG THERAPY ON PLASMA 18. OH-DOC LEVEL IN HYPERTENSIVES
RU2000111645A (ru) Способ лечения геморрагической лихорадки с почечным синдромом
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
ITRM910945A0 (it) Procedimento e composizione per ottenere una medicina contro il male secco.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee